Literature DB >> 9671416

FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders.

S Hayette1, M Gadoux, S Martel, S Bertrand, I Tigaud, J P Magaud, R Rimokh.   

Abstract

We report here the molecular study of a t(11;19)(q13;p13) translocation observed in a case of B-cell chronic lymphocytic leukemia. This translocation leads to the juxtaposition of the CCND1 gene on chromosome 11 to a new transcriptional unit on chromosome 19. The cDNA of this new evolutionarily conserved gene (named FLRG for Follistatin-Related Gene) codes for a secreted glycoprotein of the follistatin-module-protein family. FLRG is expressed in a wide range of human and murine adult tissues and its expression seems to be tightly regulated during murine embryogenesis. Its transcripts could not be detected in hematopoietic cells from all lineages and in particular in cells from lymphoid B and T lineage except in the t(11;19)-carrying leukemia described here. A great variability of expression is observed among the other tumoral cell lines analysed. Besides the t(11;19)-carrying leukemia described in this work, structural rearrangements of the FLRG locus have been found in a non-Hodgkin lymphoma, suggesting that it may play a role in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671416     DOI: 10.1038/sj.onc.1201807

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.

Authors:  Jennifer N Cash; Elizabeth B Angerman; Henry T Keutmann; Thomas B Thompson
Journal:  Mol Endocrinol       Date:  2012-05-16

2.  Gene expression in first trimester preeclampsia placenta.

Authors:  Sandra A Founds; Lauren A Terhorst; Kirk P Conrad; W Allen Hogge; Arun Jeyabalan; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2010-11-01       Impact factor: 2.522

Review 3.  Neural induction and early patterning in vertebrates.

Authors:  Mohammad Zeeshan Ozair; Chris Kintner; Ali H Brivanlou
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-10-15       Impact factor: 5.814

4.  Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

Authors:  Ferrill F Rose; Virginia B Mattis; Hansjörg Rindt; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

5.  Human placenta and fetal membranes express follistatin-related gene mRNA and protein.

Authors:  P Ciarmela; P Florio; P Toti; A Franchini; V Maguer-Satta; C Ginanneschi; E Ottaviani; F Petraglia
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

6.  Hypoxia enhances the expression of follistatin-like 3 in term human trophoblasts.

Authors:  T Biron-Shental; W T Schaiff; E Rimon; T L Shim; D M Nelson; Y Sadovsky
Journal:  Placenta       Date:  2007-10-23       Impact factor: 3.481

7.  Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.

Authors:  Y Kato; M Yashiro; S Noda; M Tendo; S Kashiwagi; Y Doi; T Nishii; J Matsuoka; Y Fuyuhiro; O Shinto; T Sawada; M Ohira; K Hirakawa
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

Review 8.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity.

Authors:  Robin Stamler; Henry T Keutmann; Yisrael Sidis; Chandramohan Kattamuri; Alan Schneyer; Thomas B Thompson
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

10.  Activin signaling as an emerging target for therapeutic interventions.

Authors:  Kunihiro Tsuchida; Masashi Nakatani; Keisuke Hitachi; Akiyoshi Uezumi; Yoshihide Sunada; Hiroshi Ageta; Kaoru Inokuchi
Journal:  Cell Commun Signal       Date:  2009-06-18       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.